Capital raised by Shuttle Pharmaceuticals
1 Form D filing · first filed Apr 2026 · Gaithersburg, MD
Executive Officer
Listed on Shuttle Pharmaceuticals's Form D filings · Co-Chief Executive Officer
Ryan Trasolini is on file as Executive Officer at Shuttle Pharmaceuticals in Gaithersburg, MD. Shuttle Pharmaceuticals has 1 Form D filing on record, $10.0M raised in total. Co-Chief Executive Officer
An orally administered radiation-sensitizing drug candidate given alongside radiotherapy, currently in a Phase 2 clinical trial in newly diagnosed IDH-wildtype glioblastoma with an unmethylated MGMT promoter.
